Geopolitics Alpha

Market closed · last trade · ETFs, Alpaca IEX

8-K - Insight Molecular Diagnostics Inc. (0001642380) (Filer)

Published . Updated .

Key takeaways

  • 8-K - Insight Molecular Diagnostics filed an 8-K with the SEC on Nov 18 (a notice of a material company event).
  • Exposed: IMDX
  • Market reaction: price tracking starts with the next trading session.

Market Call

Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.

Get these market calls by email

The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.

Free. We only use your email to send the digest and never sell or share it. See our privacy policy.

GEOPOLITICS ALPHA8-K - Insight MolecularDiagnostics Inc. (0001642380)(Filer)IMDXGEOPOLITICS ALPHA

8-K - Insight Molecular Diagnostics filed an 8-K with the SEC on Nov 18 (a notice of a material company event).

Directly affected

  • IMDX Insight Molecular Diagnostics

    Named in this report.

Indirectly affected

  • XLV Health Care Select Sector SPDR

    Health Care Select Sector SPDR holds the health sector that Insight Molecular Diagnostics belongs to, so it often moves with news about it.

  • IDXX IDEXX Laboratories+33.6% 13d

    IDEXX Laboratories is a peer of Insight Molecular Diagnostics in in vitro and in vivo diagnostic substances; rivals often move on the same news.

  • LNTH Lantheus Holdings+1.3% 30d

    Lantheus Holdings is a peer of Insight Molecular Diagnostics in in vitro and in vivo diagnostic substances; rivals often move on the same news.

  • NEOG Neogen-6.5% 30d

    Neogen is a peer of Insight Molecular Diagnostics in in vitro and in vivo diagnostic substances; rivals often move on the same news.

Price reaction, T-5 to T+3

TickerT-5T-3T-1T0T+1T+2T+3
IMDX+47.44%+18.59%baseafter closeafter closeafter closeafter close
XLV+3.66%+3.71%baseafter closeafter closeafter closeafter close
IDXX-0.08%+0.29%baseafter closeafter closeafter closeafter close
LNTH-0.74%-0.25%baseafter closeafter closeafter closeafter close
NEOG+0.99%-1.89%baseafter closeafter closeafter closeafter close

Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.

Filed: 2026-11-18 AccNo: 0001493152-26-053091 Size: 801 KB Item 1.01: Entry into a Material Definitive Agreement Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Source: sec-edgar

Insight Molecular Diagnostics (IMDX) since this story, compared with the market

CompanyWhenMoveStatus
IDXXthree days earlier+0.29%final price
IDXXfive days earlier-0.08%final price
Insight Molecular Diagnostics (IMDX)three days earlier+18.59%final price
Insight Molecular Diagnostics (IMDX)five days earlier+47.44%final price
LNTHthree days earlier-0.25%final price
LNTHfive days earlier-0.74%final price
NEOGthree days earlier-1.89%final price
NEOGfive days earlier+0.99%final price
XLVthree days earlier+3.71%final price
XLVfive days earlier+3.66%final price

Congressional trades in the stocks in this story

Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).

Who gains and who loses around Insight Molecular Diagnostics (IMDX)

Companies carried with this story

  • IMDX Insight Molecular Diagnostics

    In “8-K - Insight Molecular Diagnostics Inc. (0001642380) (Filer),” Insight Molecular Diagnostics (IMDX) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> IMDX

Insight Molecular Diagnostics (IMDX)

The 18 Nov 2026 story “8-K - Insight Molecular Diagnostics Inc. (0001642380) (Filer)” names Insight Molecular Diagnostics (IMDX) because of this story.

For Insight Molecular Diagnostics (IMDX), the reason on file says SEC 8-K filing -> direct issuer disclosure -> IMDX

How strong the case is around Insight Molecular Diagnostics (IMDX)

14 out of 100

“8-K - Insight Molecular Diagnostics Inc. (0001642380) (Filer)” scores 14 out of 100. The score uses 1 source, and 1 linked company.